-
3
-
-
0344442746
-
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
-
Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30: 843-852.
-
(2003)
Urol Clin North Am
, vol.30
, pp. 843-852
-
-
Janzen, N.K.1
Kim, H.L.2
Figlin, R.A.3
Belldegrun, A.S.4
-
4
-
-
84883177229
-
Adjuvant therapy in renal cell carcinoma-past, present, and future
-
Janowitz T, Welsh SJ, Zaki K, Mulders P, Eisen T. Adjuvant therapy in renal cell carcinoma-past, present, and future. Semin Oncol 2013; 40: 482-491.
-
(2013)
Semin Oncol
, vol.40
, pp. 482-491
-
-
Janowitz, T.1
Welsh, S.J.2
Zaki, K.3
Mulders, P.4
Eisen, T.5
-
5
-
-
84905497399
-
Expression and clinical significance of RCDG1 in renal cell carcinoma: A novel renal cancer-associated gene
-
Yu Z, Ni L, Chen D, Su Z, Yu W, Zhang Q, Wang Y, Li C, Gui Y, Lai Y. Expression and clinical significance of RCDG1 in renal cell carcinoma: A novel renal cancer-associated gene. Mol Med Rep 2014; 10: 1583-1589.
-
(2014)
Mol Med Rep
, vol.10
, pp. 1583-1589
-
-
Yu, Z.1
Ni, L.2
Chen, D.3
Su, Z.4
Yu, W.5
Zhang, Q.6
Wang, Y.7
Li, C.8
Gui, Y.9
Lai, Y.10
-
6
-
-
84903974405
-
Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients
-
Yang YQ, Chen J. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients. Genet Mol Res 2014; 13: 5011-5017.
-
(2014)
Genet Mol Res
, vol.13
, pp. 5011-5017
-
-
Yang, Y.Q.1
Chen, J.2
-
7
-
-
13844252820
-
Regulation of histone deacetylase activities
-
Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004; 93: 57-67.
-
(2004)
J Cell Biochem
, vol.93
, pp. 57-67
-
-
Sengupta, N.1
Seto, E.2
-
8
-
-
84896796054
-
Histone dea-cetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: Interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1
-
Kumar P, Tripathi S, Pandey KN. Histone dea-cetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1. J Biol Chem 2014; 289: 6991-7002.
-
(2014)
J Biol Chem
, vol.289
, pp. 6991-7002
-
-
Kumar, P.1
Tripathi, S.2
Pandey, K.N.3
-
9
-
-
0003412931
-
International Union Against Cancer
-
6th edition. New York, John: Wiley-Liss
-
Slaw CH. International Union Against Cancer. TNM Classification of Malignant Tumors. 6th edition. New York, John: Wiley-Liss; 2002.
-
(2002)
TNM Classification of Malignant Tumors
-
-
Slaw, C.H.1
-
11
-
-
33744956666
-
Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
-
Wilson AJ, Byun DS, Popova N, Murray LB, L’Italien K, Sowa Y, Arango D, Velcich A, Aug-enlicht LH, Mariadason JM. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 2006; 281: 13548-13558.
-
(2006)
J Biol Chem
, vol.281
, pp. 13548-13558
-
-
Wilson, A.J.1
Byun, D.S.2
Popova, N.3
Murray, L.B.4
L’Italien, K.5
Sowa, Y.6
Arango, D.7
Velcich, A.8
Aug-Enlicht, L.H.9
Mariadason, J.M.10
-
12
-
-
77951249270
-
Histone deacetylase 10 relieves repression on the melanogenic program by maintaining the deacetylation status of repressors
-
Lai IL, Lin TP, Yao YL, Lin CY, Hsieh MJ, Yang WM. Histone deacetylase 10 relieves repression on the melanogenic program by maintaining the deacetylation status of repressors. J Biol Chem 2010; 285: 7187-7196.
-
(2010)
J Biol Chem
, vol.285
, pp. 7187-7196
-
-
Lai, I.L.1
Lin, T.P.2
Yao, Y.L.3
Lin, C.Y.4
Hsieh, M.J.5
Yang, W.M.6
-
13
-
-
0035676731
-
Expression profile of histone deacetylase 1 in gastric cancer tissues
-
Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ, Kim DY. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 2001; 92: 1300-1304.
-
(2001)
Jpn J Cancer Res
, vol.92
, pp. 1300-1304
-
-
Choi, J.H.1
Kwon, H.J.2
Yoon, B.I.3
Kim, J.H.4
Han, S.U.5
Joo, H.J.6
Kim, D.Y.7
-
14
-
-
4544322261
-
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients
-
Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T. Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer 2004; 112: 26-32.
-
(2004)
Int J Cancer
, vol.112
, pp. 26-32
-
-
Osada, H.1
Tatematsu, Y.2
Saito, H.3
Yatabe, Y.4
Mitsudomi, T.5
Takahashi, T.6
-
15
-
-
0036493156
-
Identification of HDAC10, a novel class II human histone deacetylase containing a leucinerich domain
-
Tong JJ, Liu J, Bertos NR, Yang XJ. Identification of HDAC10, a novel class II human histone deacetylase containing a leucinerich domain. Nucleic Acids Res 2002; 30: 1114-1123.
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 1114-1123
-
-
Tong, J.J.1
Liu, J.2
Bertos, N.R.3
Yang, X.J.4
-
16
-
-
78651502605
-
Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells
-
Lee JH, Jeong EG, Choi MC, Kim SH, Park JH, Song SH, Park J, Bang YJ, Kim TY. Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells. Mol Cells 2010; 30: 107-112.
-
(2010)
Mol Cells
, vol.30
, pp. 107-112
-
-
Lee, J.H.1
Jeong, E.G.2
Choi, M.C.3
Kim, S.H.4
Park, J.H.5
Song, S.H.6
Park, J.7
Bang, Y.J.8
Kim, T.Y.9
-
17
-
-
79953157671
-
Histone deacetylases 9 and 10 are required for homologous recombination
-
Kotian S, Liyanarachchi S, Zelent A, Parvin JD. Histone deacetylases 9 and 10 are required for homologous recombination. J Biol Chem 2011; 286: 7722-7726.
-
(2011)
J Biol Chem
, vol.286
, pp. 7722-7726
-
-
Kotian, S.1
Liyanarachchi, S.2
Zelent, A.3
Parvin, J.D.4
-
18
-
-
84911496124
-
Decreased expression of histone deacetylase 10predicts poor prognosis of gastric cancer patients
-
Jin ZL, Jiang WH, Jiao F, Guo Z, Hu H, Wang L, Wang LW. Decreased expression of histone deacetylase 10predicts poor prognosis of gastric cancer patients. Int J Clin Exp Pathol 2014; 7: 5872-5879
-
(2014)
Int J Clin Exp Pathol
, vol.7
, pp. 5872-5879
-
-
Jin, Z.L.1
Jiang, W.H.2
Jiao, F.3
Guo, Z.4
Hu, H.5
Wang, L.6
Wang, L.W.7
-
19
-
-
84884784393
-
Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression
-
Song C, Zhu S, Wu C, Kang J. Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem 2013; 288: 28021-28033.
-
(2013)
J Biol Chem
, vol.288
, pp. 28021-28033
-
-
Song, C.1
Zhu, S.2
Wu, C.3
Kang, J.4
-
20
-
-
84866594008
-
ESMO Guidelines Working Group. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
vii65-71
-
Escudier B, Eisen T, Porta C, Patard JJ, Khoo V, Algaba F, Mulders P and Kataja V. Kataja V.; ESMO Guidelines Working Group. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 Suppl 7: vii65-71.
-
(2012)
Ann Oncol
, vol.23
-
-
Escudier, B.1
Eisen, T.2
Porta, C.3
Patard, J.J.4
Khoo, V.5
Algaba, F.6
Mulders, P.7
Kataja, V.8
Kataja, V.9
-
22
-
-
84905042374
-
Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A
-
Wisnieski F, Calcagno DQ, Leal MF, Chen ES, Gigek CO, Santos LC, Pontes TB, Rasmussen LT, Payao SL, Assumpcao PP, Lourenco LG, Demachki S, Artigiani R, Burbano RR, Cardoso Smith M. Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. Tumour Biol 2014; 35: 6373-6381.
-
(2014)
Tumour Biol
, vol.35
, pp. 6373-6381
-
-
Wisnieski, F.1
Calcagno, D.Q.2
Leal, M.F.3
Chen, E.S.4
Gigek, C.O.5
Santos, L.C.6
Pontes, T.B.7
Rasmussen, L.T.8
Payao, S.L.9
Assumpcao, P.P.10
Lourenco, L.G.11
Demachki, S.12
Artigiani, R.13
Burbano, R.R.14
Cardoso Smith, M.15
-
23
-
-
0037354555
-
Histone acetylation and gastrointestinal carcinogenesis
-
Yasui W, Oue N, Ono S, Mitani Y, Ito R, Na-kayama H. Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci 2003; 983: 220-231.
-
(2003)
Ann N Y Acad Sci
, vol.983
, pp. 220-231
-
-
Yasui, W.1
Oue, N.2
Ono, S.3
Mitani, Y.4
Ito, R.5
Na-Kayama, H.6
-
24
-
-
84872308972
-
His-tone deacetylase 3 inhibits expression of PUMA in gastric cancer cells
-
Feng L, Pan M, Sun J, Lu H, Shen Q, Zhang S, Jiang T, Liu L, Jin W, Chen Y, Wang X, Jin H. His-tone deacetylase 3 inhibits expression of PUMA in gastric cancer cells. J Mol Med (Berl) 2013; 91: 49-58.
-
(2013)
J Mol Med (Berl)
, vol.91
, pp. 49-58
-
-
Feng, L.1
Pan, M.2
Sun, J.3
Lu, H.4
Shen, Q.5
Zhang, S.6
Jiang, T.7
Liu, L.8
Jin, W.9
Chen, Y.10
Wang, X.11
Jin, H.12
-
25
-
-
84880333449
-
Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma
-
Du X, Zhao H, Zang L, Song N, Yang T, Dong R, Yin J, Wang C, Lu J. Overexpression of histone deacetylase 2 predicts unfavorable prognosis in human gallbladder carcinoma. Pathol Oncol Res 2013; 19: 397-403.
-
(2013)
Pathol Oncol Res
, vol.19
, pp. 397-403
-
-
Du, X.1
Zhao, H.2
Zang, L.3
Song, N.4
Yang, T.5
Dong, R.6
Yin, J.7
Wang, C.8
Lu, J.9
-
26
-
-
84876795104
-
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
-
Muller BM, Jana L, Kasajima A, Lehmann A, Prinzler J, Budczies J, Winzer KJ, Dietel M, Weichert W, Denkert C. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression. BMC Cancer 2013; 13: 215.
-
(2013)
BMC Cancer
, vol.13
, pp. 215
-
-
Muller, B.M.1
Jana, L.2
Kasajima, A.3
Lehmann, A.4
Prinzler, J.5
Budczies, J.6
Winzer, K.J.7
Dietel, M.8
Weichert, W.9
Denkert, C.10
-
27
-
-
39849105836
-
OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling
-
Feigin ME, Malbon CC. OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling. Cell Signal 2008; 20: 949-957.
-
(2008)
Cell Signal
, vol.20
, pp. 949-957
-
-
Feigin, M.E.1
Malbon, C.C.2
-
28
-
-
33745815351
-
Wnt Activation and Alternative Promoter Repression of LEF1 in Colon Cancer
-
Li TW, Ting JT, Yokoyama N, Bernstein A, van de Wetering M, Waterman M. Wnt Activation and Alternative Promoter Repression of LEF1 in Colon Cancer. Mol Cell Biol 2006; 26: 5284-5299.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 5284-5299
-
-
Li, T.W.1
Ting, J.T.2
Yokoyama, N.3
Bernstein, A.4
van de Wetering, M.5
Waterman, M.6
-
29
-
-
1242321299
-
Lymphoid enhance factor/T cell factor expression in colorectal cancer
-
Watermann ML. Lymphoid enhance factor/T cell factor expression in colorectal cancer, Cancer Metastasis Rev 2004; 23: 41-52.
-
(2004)
Cancer Metastasis Rev
, vol.23
, pp. 41-52
-
-
Watermann, M.L.1
-
31
-
-
84900450736
-
Dysregu-lation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma
-
Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Darwish OM, Haddad AQ, Khalil D, Kapur P, Sagalowsky AI, Lotan Y, Margulis V. Dysregu-lation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma. J Urol 2014; 191: 1671-1677.
-
(2014)
J Urol
, vol.191
, pp. 1671-1677
-
-
Krabbe, L.M.1
Westerman, M.E.2
Bagrodia, A.3
Gayed, B.A.4
Darwish, O.M.5
Haddad, A.Q.6
Khalil, D.7
Kapur, P.8
Sagalowsky, A.I.9
Lotan, Y.10
Margulis, V.11
-
32
-
-
84878427672
-
Impact of an Altered Wnt1/β-Catenin Expression on Clinicopa-thology and Prognosis in Clear Cell Renal Cell Carcinoma
-
Kruck S, Eyrich C, Scharpf M, Sievert KD, Fend F, Stenzl A, Bedke J. Impact of an Altered Wnt1/β-Catenin Expression on Clinicopa-thology and Prognosis in Clear Cell Renal Cell Carcinoma. Int J Mol Sci 2013; 14: 10944-10957.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 10944-10957
-
-
Kruck, S.1
Eyrich, C.2
Scharpf, M.3
Sievert, K.D.4
Fend, F.5
Stenzl, A.6
Bedke, J.7
|